AC-262,356
From Wikipedia, the free encyclopedia
 |
|
| Identifiers | |
|---|---|
|
|
| CAS Number |
|
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C18H18N2O |
| Molar mass | 278.348 g/mol |
| 3D model (JSmol) | |
|
|
|
|
| (verify) | |
AC-262536 is a drug developed by Acadia Pharmaceuticals which acts as a selective androgen receptor modulator. Chemically it possesses endo-exo isomerism, with the endo form being the active form. It acts as a partial agonist for the androgen receptor with a Ki of 5nM, and no significant affinity for any other receptors tested. In animal studies it produced a maximal effect of around 66% of the anabolic action of testosterone, but only around 27% of its potency as an androgen.[1]
References[edit]
- ^ Piu, F; Gardell, LR; Son, T; Schlienger, N; Lund, BW; Schiffer, HH; Vanover, KE; Davis, RE; Olsson, R; Bradley, SR (2008). "Pharmacological characterization of AC-262536, a novel selective androgen receptor modulator". The Journal of Steroid Biochemistry and Molecular Biology. 109 (1–2): 129–37. PMID 18164613. doi:10.1016/j.jsbmb.2007.11.001.
 |
This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
